ClinicalTrials.gg
RecruitingNCT06824961LUCASVPUpdated Aug 21, 2026

Does Increasing the Compression Pause From 3 to 5 Seconds in Mechanical Compression Devices Increase Ventilation Success Rate and Return of Spontaneous Circulation?

An interventional study of 5-second ventilation pause duration during mechanical CPR and 3-second ventilation pause duration during mechanical CPR in Cardiac Arrest (CA), sponsored by Amsterdam UMC, location VUmc. Recruiting at 2 sites in Netherlands. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-08-21.

Sponsored by Amsterdam UMC, location VUmc · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
692
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

To give chest compressions during cardiopulmonary resuscitation (CPR), mechanical chest compression devices can be used. During synchronous 30:2 CPR, the standard setting on these devices leave an automated 3-second chest compression pause after 30 compressions to facilitate caregivers in providing two ventilations. With this standard setting, research has shown that in less than half of ventilation pauses during CPR, those two ventilations are given. Increasing the ventilation pause duration to 5 seconds instead of 3 seconds is also an option following current guideline recommendations, and aligns with measured ventilation pause duration in manual CPR. Increasing pause duration to 5 seconds could result in an increased ventilation success rate. This multicenter randomized controlled trial will randomize LUCAS® mechanical compression devices to a standard setting of 3- or 5-second compression pauses. The main outcome will be the percentage of ventilation pauses in which two ventilations are successfully given. Secondary outcomes include the restoration of spontaneous circulation (ROSC), and the difference in (neurologically intact) survival. No study has been performed to evaluate this effect yet.

02

Conditions studied

  • Cardiac Arrest (CA)

Keywords

  • Advanced life support
  • Basic life support
  • Cardiac arrest
  • Cardiopulmonary resuscitation
  • CPR
  • ALS
  • BLS
  • Out-of-hospital cardiac arrest
  • OHCA
  • Mechanical chest compression devices
  • Mechanical CPR
  • Ventilation
03

In context

Heart Arrest

926 studies on the registry are indexed under Heart Arrest; 226 are open to participants now.

This study's planned enrollment of 692 is above the median of 100 across 518 interventional studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

Amsterdam UMC, location VUmc is the lead sponsor of 305 studies on the registry; 84 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (≥16 years of age)
  • OHCA patients with an attempt at cardiopulmonary resuscitation (CPR) by ambulance personnel
  • LUCAS® 3.1 has been used during the resuscitation attempt

Exclusion criteria

Exclusion Criteria:

  • Missing ambulance run report, missing or unclear impedance signal (measurement of resistance across the thorax), making it impossible to assess the number of ventilation pauses
  • Absence of a minimum of 3 assessable pauses intended for ventilation after connecting the LUCAS®
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
692 participants (estimated)

Study arms

  • Experimental
    Intervention - 5-second ventilation pause

    Patients in this group will have ventilation pauses lasting 5 seconds in between cardiac compressions given by mechanical CPR

    Other: 5-second ventilation pause duration during mechanical CPR

  • Active comparator
    Control - 3-second ventilation pauses

    Patients in this group will have ventilation pauses lasting the standard 3 seconds in between cardiac compressions given by mechanical CPR

    Other: 3-second ventilation pause duration during mechanical CPR

Interventions

  • Other5-second ventilation pause duration during mechanical CPR

    The intervention is a 5-second lasting ventilation pause during mechanical CPR

  • Other3-second ventilation pause duration during mechanical CPR

    The intervention is a 3-second lasting ventilation pause during mechanical CPR

06

What researchers measure

Primary outcomes

  1. Percentage of ventilation pauses in which two ventilations are given

    The difference in percentage of ventilation pauses in which two ventilations are given between the intervention and control group

    Time frame: From enrollment to end of mechanically assisted CPR by ambulance nurses (approximate maximum timeframe of 3 hours)

Secondary outcomes

  1. Return of spontaneous circulation (ROSC)

    The difference in percentage of participants with and without ROSC

    Time frame: From enrollment to end of cardiac arrest treatment (approximate maximum timeframe of 5 hours)

  2. Cerebral performance score (CPC score) at hospital discharge (CPC 1-2 vs. 3-4)

    The difference in percentage of participants with a CPC of 1-2 (good neurological recovery) vs. 3-4 (poor neurological recovery) at hospital discharge CPC score system: 1. Normal (good cerebral performance) 2. Moderate disability (disabled but independent) 3. Severe disability (conscious but disabled and dependent) 4. Unconscious (coma or vegetative state)

    Time frame: From enrollment to hospital discharge (approximate maximum timeframe of 3 months)

  3. Survival to hospital discharge

    The difference in percentage of participants with and without survival to hospital discharge

    Time frame: From enrollment to hospital discharge (approximate maximum timeframe of 3 months)

  4. 30-day survival

    The difference in percentage of participants with and without survival at 30 days after the cardiac arrest

    Time frame: From enrollment to 30 days after cardiac arrest

  5. Number of rhythm checks per five minutes, expected

    The difference in the number of rhythm checks per five minutes performed with and without pausing the mechanical compression device, compared to the expected number of rhythm checks in that time frame (once every two minutes) between groups

    Time frame: From enrollment to prehospital termination of CPR or handover at hospital by ambulance nurses (approximate maximum timeframe of 3 hours)

  6. Number of rhythm checks per five minutes, observed

    The difference in the number of rhythm checks per five minutes performed with and without pausing the mechanical compression device, compared to the observed number of rhythm checks in that time frame (once every two minutes) between groups

    Time frame: From enrollment to prehospital termination of CPR or handover at hospital by ambulance nurses (approximate maximum of 3 hours)

  7. Average tidal volume (ml)

    Difference in average tidal volumes (ml) between groups

    Time frame: From enrollment to end of intra-arrest ambulance monitor registration or flow/pressure measurements (approximate maximum timeframe of 3 hours)

  8. Average minute volume (ml/min)

    Difference in average minute volumes (ml/min) between groups

    Time frame: From enrollment to end of intra-arrest ambulance monitor registration or flow/pressure measurements (approximate maximum timeframe of 3 hours)

  9. Average respiratory rate (rate per minute)

    Difference in average respiratory rate (rate per minute) between groups

    Time frame: From enrollment to end of intra-arrest ambulance monitor registration or flow/pressure measurements (approximate maximum timeframe of 3 hours)

  10. Average airway pressure (cmH2O)

    Difference average airway pressures (cmH2O) between groups

    Time frame: From enrollment to end of intra-arrest ambulance monitor registration or flow/pressure measurements (approximate maximum timeframe of 3 hours)

  11. Chest compression fraction (CCF)

    Difference in chest compression fraction (CCF) between groups

    Time frame: From enrollment to end of intra-arrest registration of ambulance monitor (approximate maximum timeframe of 3 hours)

  12. Subjective experience of ambulance nurses with the mechanical CPR device and it's ventilation pause settings

    Exploratory anonymous questionnaire of subjective experience of ambulance nurses with the mechanical CPR device (the LUCAS) and it's ventilation pause settings during the resuscitation.

    Time frame: After the last inclusion of the study, with an approximate time frame of 1-2 months to respond to the anonymous survey

07

Study locations

2 of 2 sites recruiting
  • Ambulance Amsterdam
    Amsterdam, North Holland 1075LB, Netherlands
    Recruiting
  • Regionale Ambulance Voorziening Kennemerland - Ambulancezorg GGD Kennemerland
    Haarlem, North Holland 2015CK, Netherlands
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.

Of 204 non-industry interventional studies with no phase under Heart Arrest, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 47. This study's planned 12 months is below that.

Counting every sponsor, half of 218 studies reached it within 28 months; a quarter within 10 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2025
First posted
Feb 13, 2025
StartActual
Jan 15, 2026
Primary completionEst.
Jan 15, 2027
CompletionEst.
Jul 2027
Last update
Aug 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06824961
Responsible party
Prof. Dr. Patrick Schober (Principal Investigator: Professor Emergency Medicine in Anesthesiology Dr. Patrick Schober, MD, PhD., Amsterdam UMC, location VUmc) — Principal investigator
First posted
Feb 13, 2025
Start date
Jan 15, 2026
Primary completion
Jan 15, 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Aug 21, 2026

Study contacts

Lotte C Doeleman, MD
Contact
l.c.doeleman@amsterdamumc.nl
+31205665969
Hans L van Schuppen, PhD
Contact
j.l.vanschuppen@amsterdamumc.nl
+31205665969
Patrick Schober, MD, PhD
principal investigator · Amsterdam UMC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion